Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19301,236,1.36 [1.12-1.65],0.0019969620141308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14887,802,1.43 [1.28-1.60],2.2500111203548591e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19588,52,1.84 [1.31-2.60],0.000506807662196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20588,540,1.32 [1.16-1.50],2.081506536864012e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21758,253,1.38 [1.15-1.65],0.0003989569280776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21758,253,1.38 [1.15-1.65],0.0003989569280776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19564,503,1.21 [1.05-1.39],0.0071813403798776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18237,1421,1.21 [1.11-1.32],2.540009576368812e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20550,147,1.45 [1.15-1.83],0.0016840338595429
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21085,682,1.58 [1.40-1.77],1.2418346419133208e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21059,656,1.55 [1.37-1.74],4.600180547683412e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18084,1268,1.20 [1.09-1.31],0.0001453936041679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",16995,179,1.37 [1.10-1.71],0.0053439736262048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,17984,1168,1.19 [1.08-1.31],0.0004986247392789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,19743,669,1.25 [1.11-1.40],0.0002342884354896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,21254,79,1.63 [1.20-2.21],0.0017482990497085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19139,65,1.57 [1.15-2.16],0.0050465221243044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19336,262,1.33 [1.12-1.59],0.001132328647713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression,22113,224,1.32 [1.10-1.60],0.003443379461636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Depression or dysthymia,19055,191,1.38 [1.13-1.68],0.0015560000976762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,19702,1293,1.21 [1.11-1.32],2.24846658788052e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21962,533,1.22 [1.07-1.39],0.0031938502030065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,21664,235,1.53 [1.28-1.84],4.210340243162182e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,22554,184,1.52 [1.24-1.87],6.278352562741495e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22346,467,1.21 [1.05-1.39],0.0087441808924261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22880,70,1.81 [1.33-2.46],0.00015045074546
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2545,70,1.59 [1.12-2.25],0.0093073221951394
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20405,70,1.91 [1.41-2.58],3.275697405343926e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15714,3695,1.18 [1.11-1.26],6.168687194361607e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16578,2415,1.25 [1.16-1.34],7.044530543072097e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,16624,2461,1.26 [1.17-1.36],4.5743971269364503e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14269,106,1.71 [1.31-2.22],7.096402593982575e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20608,1640,1.25 [1.15-1.35],9.102488426211016e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,19889,921,1.24 [1.12-1.37],5.653367096516921e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21874,332,1.33 [1.13-1.56],0.0004684455581854
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22262,720,1.33 [1.19-1.49],4.268204894484085e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19459,491,1.37 [1.20-1.56],3.2529519184242342e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20343,1399,1.27 [1.16-1.38],8.512113926059564e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22013,310,1.31 [1.11-1.55],0.0016518786964741
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22285,184,1.36 [1.11-1.68],0.0037259125559221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22307,167,1.44 [1.16-1.79],0.0008327959707206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22391,148,1.40 [1.11-1.77],0.0039496601051081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18150,1977,1.17 [1.09-1.26],2.0795748241054063e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22320,272,1.38 [1.16-1.64],0.0002917908642718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22317,269,1.38 [1.16-1.64],0.0003459039055616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20810,838,1.21 [1.09-1.35],0.0004033713489152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21902,652,1.21 [1.07-1.36],0.0020209573050756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Asthma,15827,652,1.28 [1.14-1.45],4.882945283461492e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15496,652,1.30 [1.15-1.46],2.570529187336263e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15817,642,1.30 [1.15-1.46],2.911486142639948e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15488,5479,1.10 [1.05-1.17],0.000400063555544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17839,315,1.27 [1.08-1.50],0.0046487871801956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19480,1956,1.11 [1.03-1.19],0.0073244532101788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22426,585,1.19 [1.05-1.35],0.0063022457194659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22136,359,1.28 [1.10-1.49],0.0017505009562868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16662,88,1.53 [1.14-2.05],0.004278961241894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23016,85,1.48 [1.10-1.98],0.009192694637298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23021,75,1.56 [1.15-2.11],0.0042879705931925
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20544,258,1.29 [1.08-1.55],0.0050039030950545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20084,59,1.59 [1.14-2.23],0.0066802634430585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17844,2333,1.21 [1.13-1.30],8.323700513171076e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20524,298,1.55 [1.32-1.82],5.482628087897551e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20557,73,1.66 [1.24-2.24],0.0007244250006462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20573,89,1.91 [1.48-2.45],5.375284537694524e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20574,90,1.68 [1.28-2.20],0.0001832844209507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22753,77,1.53 [1.13-2.08],0.0059406415144769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20361,73,1.61 [1.19-2.19],0.0020316921279764
